Clinical Trial Update: А Dose-finding Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder [Phase 2]

View source ↗

Summary

Phase 2 dose-finding trial for CD-008-0045 in generalized anxiety disorder has completed, assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• CD-008-0045

Snippet

Sponsor: ChemRar Research and Development Institute, LLC | Conditions: Anxiety Disorder Generalized | Phase 2 | Status: COMPLETED